Reaction

Peripheral Arterial Occlusive Disease reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,050 reports · 143 co-occurring drugs

As of the last recalculation, Peripheral Arterial Occlusive Disease appears in 4,050 FAERS reports alongside 143 co-occurring drug terms. The strongest observed disproportionality signal is NILOTINIB (PRR 79.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Nilotinib	410	79.4	80.5
Inclisiran	37	23.9	24.0
Imatinib	54	15.9	16.0
Bosutinib	25	14.4	14.4
Clopidogrel	413	11.8	11.8
Dapagliflozin	66	10.9	11.0
Paricalcitol	29	10.6	10.6
Prasugrel Hydrochloride	20	10.2	10.2
Epoetin Alfa	23	10.0	10.0
Clopidogrel Bisulfate	188	9.9	9.9
Torsemide	62	9.8	9.8
Candesartan	59	8.6	8.6
Methoxy Polyethylene Glycol-Epoetin Beta	18	8.4	8.4
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	13	8.2	8.2
Bisoprolol Fumarate	193	7.6	7.6
Ezetimibe	107	7.5	7.5
Human Insulin	18	7.4	7.4
Dasatinib	53	7.4	7.4
Metolazone	16	7.3	7.4
Amlodipine Besylate And Benazepril Hydrochloride	13	7.3	7.3
Valsartan Oral	74	7.1	7.1
Nitroglycerin	73	7.1	7.1
Febuxostat Tablets 40 Mg	14	7.1	7.1
Febuxostat Tablets 80 Mg	14	7.1	7.1
Pitavastatin Calcium	14	7.1	7.1
Iron Sucrose	13	7.0	7.0
Insulin Glargine-Yfgn	29	6.9	6.9
Darbepoetin Alfa	67	6.5	6.5
Isosorbide Dinitrate	24	6.3	6.4
Doxazosin	34	6.3	6.3
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	37	6.2	6.2
Empagliflozin	79	6.1	6.1
Aspirin 81 Mg	535	6.0	6.0
Aspirin 325 Mg	534	6.0	6.0
Acetylcysteine	11	6.0	6.0
Captopril	11	5.9	5.9
Cimetidine	11	5.9	5.9
Aspirin	542	5.8	5.8
Nebivolol	18	5.8	5.8
Magnesium Hydroxide	15	5.7	5.7
Calcitriol Capsules 0.25 Mcg	22	5.7	5.7
Calcitriol Capsules 0.5 Mcg	22	5.7	5.7
Linagliptin	20	5.7	5.7
Calcitriol	22	5.6	5.6
Insulin Degludec	25	5.5	5.5
Doxazosin Mesylate	38	5.5	5.5
Ranolazine	11	5.4	5.4
Metoprolol Tartrate Injection	190	5.4	5.4
Losartan Potassium And Hydrochlorothiazide	12	5.3	5.3
Niacin	12	5.3	5.3
Rosuvastatin	199	5.2	5.2
Calcium Carbonate	67	5.2	5.2
Valsartan	104	5.2	5.2
Indapamide	18	5.2	5.2
Cefazolin	9	5.1	5.1
Carvedilol	129	5.0	5.0
Ramipril	117	5.0	5.0
Insulin	53	4.9	4.9
Digoxin	68	4.9	4.9
Febuxostat	16	4.9	4.9
Antacid	45	4.9	4.9
Simvastatin	226	4.9	4.9
Canagliflozin	28	4.8	4.8
Rivaroxaban	187	4.8	4.8
Metoprolol Tartrate	241	4.8	4.8
Metoprolol	224	4.7	4.7
Isosorbide Mononitrate	19	4.7	4.7
Allopurinol	139	4.7	4.7
Amlodipine Besylate And Valsartan	10	4.7	4.7
Glimepiride	35	4.6	4.7
Sitagliptin And Metformin Hydrochloride	19	4.5	4.5
Meclizine Hcl 12.5Mg	12	4.5	4.5
Meclizine Hcl 25Mg	12	4.5	4.5
Meclizine Hcl 12.5 Mg	12	4.5	4.5
Meclizine Hcl 25 Mg	12	4.5	4.5
Insulin Human	33	4.3	4.3
Nebivolol Hydrochloride	28	4.3	4.3
Cefazolin Sodium	10	4.3	4.3
Heparin Sodium	11	4.1	4.1
Ezetimibe And Simvastatin	12	4.1	4.1
Nifedipine	37	4.1	4.1
Insulin Glulisine	8	4.0	4.1
Metoprolol Succinate	67	4.0	4.0
Magnesium Oxide	31	3.8	3.8
Enalapril	41	3.8	3.8
Dutasteride	6	3.8	3.8
Romiplostim	11	3.8	3.8
Ticagrelor	23	3.7	3.7
Bicalutamide	11	3.7	3.7
Furosemide	273	3.7	3.7
Amiodarone Hydrochloride	8	3.7	3.7
Sitagliptin	51	3.7	3.7
Glyburide	17	3.6	3.6
Insulin Aspart	46	3.6	3.6
Pemetrexed	15	3.6	3.6
Sevelamer Carbonate	8	3.6	3.6
Amlodipine	179	3.5	3.5
Imatinib Mesylate	19	3.5	3.5
Erythropoietin	14	3.5	3.5
Ferrous Sulfate	34	3.5	3.5
Interferon Beta-1B	13	3.5	3.5
Lovastatin	17	3.4	3.4
Hydroxyurea	14	3.4	3.4
Metoprolol Succinate Er Tablets	41	3.4	3.4
Atorvastatin Calcium	159	3.4	3.4
Lisinopril And Hydrochlorothiazide Tablets	5	3.3	3.3
Atorvastatin Calcium, Film Coated	44	3.2	3.2
Eplerenone	8	3.2	3.2
Peginterferon Beta-1A	8	3.1	3.1
Insulin Glargine	147	3.1	3.1
Sacubitril And Valsartan	65	2.9	2.9
Testosterone Cypionate	5	2.9	2.9
Latanoprost	28	2.9	2.9
Apixaban	36	2.8	2.8
Sorafenib	11	2.7	2.7
Alirocumab	13	2.7	2.7
Dabigatran Etexilate	39	2.6	2.6
Pemetrexed Disodium	19	2.6	2.6
Insulin Lispro	68	2.6	2.6
Timolol	6	2.6	2.6
Acalabrutinib	6	2.5	2.5
Pioglitazone	21	2.5	2.5
Tolvaptan	7	2.5	2.5
Icosapent Ethyl	4	2.4	2.4
Alteplase	7	2.4	2.4
Dabigatran Etexilate Mesylate	32	2.3	2.3
Rifaximin	9	2.2	2.2
Risankizumab-Rzaa	34	2.1	2.1
Liraglutide	20	2.1	2.1
Varenicline Tartrate	32	2.1	2.1
Esketamine Hydrochloride	7	2.0	2.0
Faricimab	3	1.9	1.9
Romosozumab-Aqqg	5	1.9	1.9
Atezolizumab	14	1.9	1.9
Selinexor	3	1.8	1.8
Drospirenone And Ethinyl Estradiol	15	1.7	1.7
Ranibizumab	9	1.7	1.7
Exenatide	17	1.7	1.7
Cinacalcet Hydrochloride	15	1.7	1.7
Patiromer	4	1.5	1.5
Evolocumab	39	1.2	1.2
Relugolix	5	1.1	1.1
Droxidopa	4	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.